ACU trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ACU achieves its forward estimates and maintains a stable P/E multiple of 23.5x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 24, 2026, Acme United Corporation (ACU) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $176M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ACU trades at a trailing P/E of 18.5x and forward P/E of 23.5x. The forward PEG ratio of 15.56 reflects a premium valuation. Analysts expect EPS to grow -4.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $44.78, with bear and bull scenarios of $28.21 and $59.01 respectively. Model confidence stands at 40/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
LCUTLifetime Brands, Inc. | $192M | $8.41 | $7.00 | -16.8% | Hold | 12.1x | 3 |
LESLLeslie's, Inc. | $92M | $9.88 | — | — | — | — | — |
SMIDSmith-Midland Corporation | $160M | $30.18 | — | — | — | — | — |
ACCOACCO Brands Corporation | $359M | $3.89 | $8.00 | +105.7% | Hold | 4.5x | 7 |
FONRFONAR Corporation | $118M | $19.09 | — | — | — | — | — |
SWKStanley Black & Decker, Inc. | $13.0B | $83.81 | $88.67 | +5.8% | Hold | 18.4x | 37 |
KMTKennametal Inc. | $2.7B | $35.10 | $35.75 | +1.9% | Hold | 9.0x | 23 |
SPXCSPX Technologies, Inc. | $11.8B | $236.07 | $252.00 | +6.7% | Buy | 29.4x | 12 |
TRSTriMas Corporation | $1.6B | $43.10 | $38.00 | -11.8% | Buy | 25.8x | 14 |
MMM3M Company | $84.4B | $161.84 | $166.75 | +3.0% | Hold | 18.6x | 33 |
Quick answers to the most common questions about buying ACU stock.
The consensus price target for ACU is $N/A, close to the current price of $46.12 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
ACU has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
ACU trades at a forward P/E of 23.5306x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $N/A for ACU, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $59 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ACU is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ACU stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $45, with bear/bull scenarios of $28/$59.
Our quantitative valuation model calculates ACU's fair value at $45 (base case), with a bear case of $28 and bull case of $59. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.
ACU trades at a forward P/E ratio of 23.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
ACU appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ACU analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $28-$59 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.